Literature DB >> 2469893

Alpha 1-adrenoceptor responsiveness: the influence of age.

H L Elliott1.   

Abstract

The association between increasing age and increasing blood pressure is the principal factor that has compromised the interpretation of many studies attempting to evaluate the effects of age alone on alpha-adrenergic mechanisms and the antihypertensive response to alpha 1-adrenoceptor antagonists. In clinical studies of antihypertensive response, difficulties of interpretation have been created by the failure to take into account the statistical association between the initial blood pressure and magnitude of the blood pressure fall and also the potential influence of age-related alterations in pharmacokinetics and drug disposition. Only a few studies have integrated pharmacokinetic and pharmacodynamic information to quantify more accurately responsiveness to alpha-antagonist drugs. These studies have failed to show any independent age-related differential effect but have confirmed that the pretreatment blood pressure, irrespective of age, is a significant determinant of the antihypertensive response.

Mesh:

Substances:

Year:  1988        PMID: 2469893

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

Review 1.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

Review 2.  Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

Review 3.  The clinical implications of ageing for rational drug therapy.

Authors:  Shaojun Shi; Klaus Mörike; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-01-05       Impact factor: 2.953

Review 4.  Nilvadipine. A review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina.

Authors:  R N Brogden; D McTavish
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

5.  Serotonin-induced platelet aggregation predicts the antihypertensive response to serotonin receptor antagonists.

Authors:  G Gleerup; B Persson; T Hedner; K Winther
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.